|
Sign In to gain access to subscriptions and/or personal tools.
|
Diagnostic Arrays for Epigenetic MarkersYU-WEI LEU AND TIM H.-M. HUANG, Human Cancer Genetics Program, The Ohio State University Comprehensive Cancer Center, Medical Research Facility, Columbus, Ohio 43210
References
- Jones, P.A. and S.B. Baylin (2002). "The Fundamental Role of Epigenetic Events in Cancer." Nature Rev Genet 3: 415—28.[Web of Science][Medline]
[Order article via Infotrieve]
- Shi, H., S.H. Wei, Y.W. Leu, F. Rahmatpanah, J.C. Liu, P.S. Yan, K.P. Nephew, and T.H.M. Huang (2003). "Triple Analysis of the Cancer Epigenome: An Integrated Microarray System for Analyzing Gene Expression, DNA Methylation, and Histone Acetylation." Cancer Res 63: 2164—71.[Abstract/Free Full Text]
- Wei, S.H., C.M. Chen, G. Strathdee, J. Harnsomburana, C.R. Shyu, F. Rahmatpanah, H. Shi, S.W. Ng, P.S. Yan, K.P. Nephew, R. Brown, and T.H.M. Huang (2002). "Methylation Microarray Analysis of Late-Stage Ovarian Carcinomas Distinguishes Progression-Free Survival in Patients and Identifies Candidate Epigenetic Markers." Clin Cancer Res 8: 2246— 52.
- Yan, P.S., C.M. Chen, H. Shi, F. Rahmatpanah, S.H. Wei, C.W. Caldwell, and T.H.M. Huang (2001). "Dissecting Complex Epigenetic Alterations in Breast Cancer Using CpG Island Microarrays." Cancer Res 61: 8375—80.[Abstract/Free Full Text]
Toxicologic Pathology, Vol. 32, No. 1,
139 (2004)
DOI: 10.1080/714592161

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|